New usage paradigms in antibody therapy: induction or true prophylaxis?

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 31; no. 1-2; pp. 1234 - 1235
Main Author Kirkman, R.L
Format Journal Article Conference Proceeding
LanguageEnglish
Published New York, NY Elsevier Inc 01.02.1999
Elsevier Science
Subjects
Antibodies, Monoclonal - therapeutic use
Basiliximab
Biological and medical sciences
Graft Rejection - immunology
Graft Rejection - therapy
Humans
Immunomodulators
Immunopathology
Immunosuppression - methods
Immunotherapy (general aspects)
Medical sciences
Models, Immunological
Pharmacology. Drug treatments
Recombinant Fusion Proteins
Recombinant Proteins - therapeutic use
Transplantation Immunology
Daclizumab
Prevention
Treatment
Antilymphocyte globulin
Antibody
Basiliximab
Immunotherapy
Monoclonal antibody
Immunosuppressive agent
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0041-1345
1873-2623
DOI:10.1016/S0041-1345(98)01976-9